Amgen Inc vs. BioStem Technologies, Inc. Common Stock
Amgen Inc and BioStem Technologies, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| AMGN | BSEM | |
|---|---|---|
| Market Cap | $238.06 billion | $65.26 million |
| Revenue (TTM) | $38.09 billion | — |
| Net Income (TTM) | $8.74 billion | — |
AMGN leads on 1 of 1 size & scale factors.
Valuation
| AMGN | BSEM | |
|---|---|---|
| P/E Ratio | 27.35 | — |
| Price / Book | 20.37 | — |
| Price / Sales | 6.25 | — |
AMGN and BSEM split the valuation factors evenly.
Profitability
| AMGN | BSEM | |
|---|---|---|
| Net Margin | 22.95% | — |
| Return on Equity | 74.80% | — |
AMGN and BSEM split the profitability factors evenly.
Dividend
| AMGN | BSEM | |
|---|---|---|
| Dividend Yield | 2.29% | — |
| Payout Ratio | 62.61 | — |
AMGN and BSEM split the dividend factors evenly.
Risk & Sentiment
| AMGN | BSEM | |
|---|---|---|
| Short Interest | 1.66% | 0.00% |
BSEM leads on 1 of 1 risk & sentiment factors.
Dig deeper: AMGN overview, AMGN financials, BSEM overview, BSEM financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.